| 李 瑶,高颖生,吕晓丹,林森森,袁胜涛.巨噬细胞游走抑制因子在肿瘤中的作用研究进展[J].,2017,17(20):3992-3995 |
| 巨噬细胞游走抑制因子在肿瘤中的作用研究进展 |
| Macrophage Migration Inhibitory Factor in the Progression of Cancer |
| 投稿时间：2017-01-24 修订日期：2017-02-18 |
| DOI：10.13241/j.cnki.pmb.2017.20.045 |
| 中文关键词: 巨噬细胞游走抑制因子 肿瘤治疗 靶点 |
| 英文关键词: Macrophage migration inhibitory factor Tumor therapy Target |
| 基金项目:国家自然科学基金项目(81573456，81302794)；江苏省自然科学基金项目（BK20161598）；国家高技术研究发展计划(863计划) （2014AA022208） |
|
| 摘要点击次数: 373 |
| 全文下载次数: 244 |
| 中文摘要: |
| 摘要：巨噬细胞游走抑制因子是一种具有多种生物学效应的糖蛋白，可以调节不同的下游信号如ERK/AKT、NF-κB等通路参与肿瘤细胞增殖、侵袭、转移、血管形成和自噬等生物学过程。临床相关研究表明巨噬细胞游走抑制因子与肿瘤发生发展关系密切，且在乳腺癌、肺癌、前列腺癌、甲状腺癌、结肠癌等多种肿瘤中高表达，因此以巨噬细胞游走抑制因子为靶点的相关肿瘤治疗逐渐受到重视。有关巨噬细胞游走抑制因子拓扑异构酶活性抑制剂及巨噬细胞游走抑制因子中和抗体在肿瘤治疗中的研究越来越多。本文对巨噬细胞游走抑制因子在肿瘤发生发展中的作用以及针对巨噬细胞游走抑制因子进行的肿瘤治疗研究作一综述。 |
| 英文摘要: |
| ABSTRACT: Macrophage migration inhibitory factor (MIF) is a glycoprotein with many biological effects, it participates in lots of biological processes such as tumor proliferation, invasion, metastasis, angiogenesis and autophagy by regulation of different downstream signal pathways like ERK/AKT and NF-κB. Experimental and clinical researches show that MIF is closely related with cancer progression and is high expressed in various types of tumors such as breast cancer, lung cancer, prostate cancer, thyroid cancer and clonal cancer. MIF topoisomerase inhibitor and anti-MIF antibody therapy are now under investigation. Here, we review the effect of MIF in tumorigenesis, and discuss research progress of MIF in cancer treatment. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
